Review Of Recommendations Of The Advisory Committee On Immunization Practices, Centers For Disease Control And Prevention, On Varicella Vaccine

After US licensure of the Merck varicella vaccine for immunocompetent persons on 17 March 1995, the Advisory Committee on Immunization Practices finalized draft recommendations for varicella prevention in the public health sector. These recommendations call for routine vaccination of children at age...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 1996-11, Vol.174 (Supplement-3), p.S342-S344
1. Verfasser: Holmes, Sandra J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S344
container_issue Supplement-3
container_start_page S342
container_title The Journal of infectious diseases
container_volume 174
creator Holmes, Sandra J.
description After US licensure of the Merck varicella vaccine for immunocompetent persons on 17 March 1995, the Advisory Committee on Immunization Practices finalized draft recommendations for varicella prevention in the public health sector. These recommendations call for routine vaccination of children at age 12–18 months with a single dose of the vaccine. Varicella vaccine preferably should be given to children at the same time they receive measles-mumps-rubella vaccine and may be given at the same time as other vaccines recommended at this age. Children ages 18 months to 12 years who have not been vaccinated as part of the routine schedule and who lack a reliable history of varicella should be vaccinated. Vaccination is desirable for persons ≤5? 13 years old without a reliable history of varicella. Special efforts should be made to assess the immunity of and to vaccinate susceptible persons who have close contact with persons at high risk for complications, including family contacts of immunocompromised individuals and health care workers.
doi_str_mv 10.1093/infdis/174.Supplement_3.S342
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_78491621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30126275</jstor_id><sourcerecordid>30126275</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-dd97005c885d3b68326806b6692caab952cb0376c7a9286181a3a52e506350b83</originalsourceid><addsrcrecordid>eNpdkVtv0zAcxSMEGmXwEZAsNPG0dL7El0i8dB1jkyYVbeWivViO869wSZxiJ93Gl-Ar466lIJ5s-XfO8ZFOlh0RPCa4ZCfOL2oXT4gsxjfDatVAC77XbHzDCvokGxHOZC4EYU-zEcaU5kSV5fPsRYxLjHHBhDzIDpQqBS_YKPt1DWsHd2i2QNdguzZl1aZ3nY-bp_k3QJN67WIXHtA0Udf3AGjm0WXbDt79fJSij8HY3lmIx2iaukCI6LwL6MxFMBGS0feha9DE10kK6yRJruNNzGcTkq9pTLpZ6zy8zJ4tTBPh1e48zD6dv59PL_Kr2YfL6eQqt4VSfV7XpcSYW6V4zSqhGBUKi0qIklpjqpJTW2EmhZWmpEoQRQwznALHgnFcKXaYvd3mrkL3Y4DY69bFxyYeuiFqqYqSCEqS8M1_wmU3BJ-6aUpZSaXkm7R3W5ENXYwBFnoVXGvCgyZYb0bT29F0Gk3_O5rejJbsr3d_DFUL9d68Wynxox030ZpmEYy3KeyPjBYKF4L8jVnGvgt7zDChgkqeeL7lLvZwv-cmfNdCMsn1xddb_WV6Ss8ovtVz9htD1b7B</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223927758</pqid></control><display><type>article</type><title>Review Of Recommendations Of The Advisory Committee On Immunization Practices, Centers For Disease Control And Prevention, On Varicella Vaccine</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Holmes, Sandra J.</creator><creatorcontrib>Holmes, Sandra J.</creatorcontrib><description>After US licensure of the Merck varicella vaccine for immunocompetent persons on 17 March 1995, the Advisory Committee on Immunization Practices finalized draft recommendations for varicella prevention in the public health sector. These recommendations call for routine vaccination of children at age 12–18 months with a single dose of the vaccine. Varicella vaccine preferably should be given to children at the same time they receive measles-mumps-rubella vaccine and may be given at the same time as other vaccines recommended at this age. Children ages 18 months to 12 years who have not been vaccinated as part of the routine schedule and who lack a reliable history of varicella should be vaccinated. Vaccination is desirable for persons ≤5? 13 years old without a reliable history of varicella. Special efforts should be made to assess the immunity of and to vaccinate susceptible persons who have close contact with persons at high risk for complications, including family contacts of immunocompromised individuals and health care workers.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/174.Supplement_3.S342</identifier><identifier>PMID: 8896543</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Adolescent ; Adult ; Biological and medical sciences ; Chickenpox ; Chickenpox - prevention &amp; control ; Chickenpox vaccine ; Chickenpox Vaccine - adverse effects ; Chickenpox Vaccine - immunology ; Child ; Child, Preschool ; Children ; Disease risk ; Dosage ; Epidemiology. Vaccinations ; General aspects ; Health care administration ; Humans ; Immunity ; Immunization ; Infant ; Infectious diseases ; Medical sciences ; Recommendations ; Vaccination</subject><ispartof>The Journal of infectious diseases, 1996-11, Vol.174 (Supplement-3), p.S342-S344</ispartof><rights>1997 INIST-CNRS</rights><rights>Copyright University of Chicago, acting through its Press Nov 1996</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-dd97005c885d3b68326806b6692caab952cb0376c7a9286181a3a52e506350b83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30126275$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30126275$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,803,23930,23931,25140,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2480461$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8896543$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holmes, Sandra J.</creatorcontrib><title>Review Of Recommendations Of The Advisory Committee On Immunization Practices, Centers For Disease Control And Prevention, On Varicella Vaccine</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>After US licensure of the Merck varicella vaccine for immunocompetent persons on 17 March 1995, the Advisory Committee on Immunization Practices finalized draft recommendations for varicella prevention in the public health sector. These recommendations call for routine vaccination of children at age 12–18 months with a single dose of the vaccine. Varicella vaccine preferably should be given to children at the same time they receive measles-mumps-rubella vaccine and may be given at the same time as other vaccines recommended at this age. Children ages 18 months to 12 years who have not been vaccinated as part of the routine schedule and who lack a reliable history of varicella should be vaccinated. Vaccination is desirable for persons ≤5? 13 years old without a reliable history of varicella. Special efforts should be made to assess the immunity of and to vaccinate susceptible persons who have close contact with persons at high risk for complications, including family contacts of immunocompromised individuals and health care workers.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Chickenpox</subject><subject>Chickenpox - prevention &amp; control</subject><subject>Chickenpox vaccine</subject><subject>Chickenpox Vaccine - adverse effects</subject><subject>Chickenpox Vaccine - immunology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Disease risk</subject><subject>Dosage</subject><subject>Epidemiology. Vaccinations</subject><subject>General aspects</subject><subject>Health care administration</subject><subject>Humans</subject><subject>Immunity</subject><subject>Immunization</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Recommendations</subject><subject>Vaccination</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkVtv0zAcxSMEGmXwEZAsNPG0dL7El0i8dB1jkyYVbeWivViO869wSZxiJ93Gl-Ar466lIJ5s-XfO8ZFOlh0RPCa4ZCfOL2oXT4gsxjfDatVAC77XbHzDCvokGxHOZC4EYU-zEcaU5kSV5fPsRYxLjHHBhDzIDpQqBS_YKPt1DWsHd2i2QNdguzZl1aZ3nY-bp_k3QJN67WIXHtA0Udf3AGjm0WXbDt79fJSij8HY3lmIx2iaukCI6LwL6MxFMBGS0feha9DE10kK6yRJruNNzGcTkq9pTLpZ6zy8zJ4tTBPh1e48zD6dv59PL_Kr2YfL6eQqt4VSfV7XpcSYW6V4zSqhGBUKi0qIklpjqpJTW2EmhZWmpEoQRQwznALHgnFcKXaYvd3mrkL3Y4DY69bFxyYeuiFqqYqSCEqS8M1_wmU3BJ-6aUpZSaXkm7R3W5ENXYwBFnoVXGvCgyZYb0bT29F0Gk3_O5rejJbsr3d_DFUL9d68Wynxox030ZpmEYy3KeyPjBYKF4L8jVnGvgt7zDChgkqeeL7lLvZwv-cmfNdCMsn1xddb_WV6Ss8ovtVz9htD1b7B</recordid><startdate>19961101</startdate><enddate>19961101</enddate><creator>Holmes, Sandra J.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19961101</creationdate><title>Review Of Recommendations Of The Advisory Committee On Immunization Practices, Centers For Disease Control And Prevention, On Varicella Vaccine</title><author>Holmes, Sandra J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-dd97005c885d3b68326806b6692caab952cb0376c7a9286181a3a52e506350b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Chickenpox</topic><topic>Chickenpox - prevention &amp; control</topic><topic>Chickenpox vaccine</topic><topic>Chickenpox Vaccine - adverse effects</topic><topic>Chickenpox Vaccine - immunology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Disease risk</topic><topic>Dosage</topic><topic>Epidemiology. Vaccinations</topic><topic>General aspects</topic><topic>Health care administration</topic><topic>Humans</topic><topic>Immunity</topic><topic>Immunization</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Recommendations</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holmes, Sandra J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holmes, Sandra J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review Of Recommendations Of The Advisory Committee On Immunization Practices, Centers For Disease Control And Prevention, On Varicella Vaccine</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1996-11-01</date><risdate>1996</risdate><volume>174</volume><issue>Supplement-3</issue><spage>S342</spage><epage>S344</epage><pages>S342-S344</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>After US licensure of the Merck varicella vaccine for immunocompetent persons on 17 March 1995, the Advisory Committee on Immunization Practices finalized draft recommendations for varicella prevention in the public health sector. These recommendations call for routine vaccination of children at age 12–18 months with a single dose of the vaccine. Varicella vaccine preferably should be given to children at the same time they receive measles-mumps-rubella vaccine and may be given at the same time as other vaccines recommended at this age. Children ages 18 months to 12 years who have not been vaccinated as part of the routine schedule and who lack a reliable history of varicella should be vaccinated. Vaccination is desirable for persons ≤5? 13 years old without a reliable history of varicella. Special efforts should be made to assess the immunity of and to vaccinate susceptible persons who have close contact with persons at high risk for complications, including family contacts of immunocompromised individuals and health care workers.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>8896543</pmid><doi>10.1093/infdis/174.Supplement_3.S342</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1996-11, Vol.174 (Supplement-3), p.S342-S344
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_78491621
source MEDLINE; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current)
subjects Adolescent
Adult
Biological and medical sciences
Chickenpox
Chickenpox - prevention & control
Chickenpox vaccine
Chickenpox Vaccine - adverse effects
Chickenpox Vaccine - immunology
Child
Child, Preschool
Children
Disease risk
Dosage
Epidemiology. Vaccinations
General aspects
Health care administration
Humans
Immunity
Immunization
Infant
Infectious diseases
Medical sciences
Recommendations
Vaccination
title Review Of Recommendations Of The Advisory Committee On Immunization Practices, Centers For Disease Control And Prevention, On Varicella Vaccine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A17%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20Of%20Recommendations%20Of%20The%20Advisory%20Committee%20On%20Immunization%20Practices,%20Centers%20For%20Disease%20Control%20And%20Prevention,%20On%20Varicella%20Vaccine&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Holmes,%20Sandra%20J.&rft.date=1996-11-01&rft.volume=174&rft.issue=Supplement-3&rft.spage=S342&rft.epage=S344&rft.pages=S342-S344&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/174.Supplement_3.S342&rft_dat=%3Cjstor_proqu%3E30126275%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223927758&rft_id=info:pmid/8896543&rft_jstor_id=30126275&rfr_iscdi=true